Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABM NASDAQ:ADV NASDAQ:MXCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMABM Industries$40.20+0.2%$39.24$36.96▼$52.94$2.35B0.74403,406 shs390,857 shsADVAdvantage Solutions$42.31+3.6%$29.05$12.23▼$53.63$562.51M2.2191,294 shs149,418 shsMXCTMaxCyte$1.04-1.9%$0.84$0.64▼$2.40$111.41M1.371.03 million shs809,075 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMABM Industries0.00%+2.09%-0.75%-11.67%-21.94%ADVAdvantage Solutions0.00%+23.03%+29.71%+173.01%+44.65%MXCTMaxCyte0.00%0.00%+20.71%+40.65%-52.73%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMABM Industries$40.20+0.2%$39.24$36.96▼$52.94$2.35B0.74403,406 shs390,857 shsADVAdvantage Solutions$42.31+3.6%$29.05$12.23▼$53.63$562.51M2.2191,294 shs149,418 shsMXCTMaxCyte$1.04-1.9%$0.84$0.64▼$2.40$111.41M1.371.03 million shs809,075 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMABM Industries0.00%+2.09%-0.75%-11.67%-21.94%ADVAdvantage Solutions0.00%+23.03%+29.71%+173.01%+44.65%MXCTMaxCyte0.00%0.00%+20.71%+40.65%-52.73%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMABM Industries 2.20Hold$46.2515.06% UpsideADVAdvantage Solutions 2.00Hold$34.38-18.75% DownsideMXCTMaxCyte 2.20Hold$5.50428.85% UpsideCurrent Analyst Ratings BreakdownLatest MXCT, ADV, MAST, and ABM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/7/2026ADVAdvantage Solutions Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$37.50 ➝ $50.005/6/2026ADVAdvantage Solutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/4/2026ABMABM Industries Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/4/2026ADVAdvantage Solutions Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/24/2026MXCTMaxCyte Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026ABMABM Industries Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)3/25/2026MXCTMaxCyte Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $5.003/12/2026ADVAdvantage Solutions Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/11/2026ABMABM Industries UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$51.00 ➝ $45.003/11/2026ABMABM Industries Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$47.00 ➝ $45.003/11/2026ABMABM Industries Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$52.00 ➝ $45.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMABM Industries$8.75B0.27$5.25 per share7.66$29.16 per share1.38ADVAdvantage Solutions$3.59B0.16$14.20 per share2.98$35.96 per share1.18MXCTMaxCyte$33.03M3.37N/AN/A$1.57 per share0.66Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMABM Industries$162.30M$2.5415.829.18N/A1.78%11.77%3.99%6/5/2026 (Estimated)ADVAdvantage Solutions-$227.74M-$18.74N/A7.00N/A-6.78%-37.22%-7.93%8/6/2026 (Estimated)MXCTMaxCyte-$44.63M-$0.37N/AN/AN/A-121.16%-20.03%-17.14%8/12/2026 (Estimated)Latest MXCT, ADV, MAST, and ABM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/5/2026Q2 2026ABMABM Industries$0.92N/AN/AN/A$2.21 billionN/A5/12/2026Q1 2026MXCTMaxCyte-$0.10-$0.04+$0.06-$0.04$7.28 million$6.22 million3/24/2026Q4 2025MXCTMaxCyte-$0.08-$0.06+$0.02-$0.09$9.16 million$6.76 million3/10/2026Q1 2026ABMABM Industries$0.87$0.83-$0.04$0.64$2.19 billion$2.24 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABMABM Industries$1.162.89%+7.45%45.67%59 YearsADVAdvantage SolutionsN/AN/AN/AN/AN/AMXCTMaxCyteN/AN/AN/AN/AN/ALatest MXCT, ADV, MAST, and ABM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/10/2026ABMABM Industriesquarterly$0.293%4/2/20264/2/20265/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMABM Industries0.931.501.50ADVAdvantage Solutions3.181.951.95MXCTMaxCyteN/A12.0411.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMABM Industries91.62%ADVAdvantage Solutions49.82%MXCTMaxCyte68.81%Insider OwnershipCompanyInsider OwnershipABMABM Industries0.90%ADVAdvantage Solutions9.40%MXCTMaxCyte4.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMABM Industries113,00058.53 million58.01 millionOptionableADVAdvantage Solutions73,00013.30 million12.05 millionOptionableMXCTMaxCyte80107.12 million102.73 millionOptionableMXCT, ADV, MAST, and ABM HeadlinesRecent News About These CompaniesMaxCyte, Inc. (NASDAQ:MXCT) Receives $5.50 Average PT from BrokeragesMay 19, 2026 | americanbankingnews.comMaxCyte (NASDAQ:MXCT) Raised to Hold at Wall Street ZenMay 16, 2026 | americanbankingnews.comHere’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for InvestorsMay 13, 2026 | insidermonkey.comMaxCyte, Inc. (MXCT) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comMaxCyte Q1 Earnings Call HighlightsMay 12, 2026 | marketbeat.comMaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue EstimatesMay 12, 2026 | zacks.comMaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 GuidanceMay 12, 2026 | globenewswire.comMaxCyte (MXCT) Expected to Announce Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comMaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026April 29, 2026 | globenewswire.comMaxCyte (MXCT) price target decreased by 11.67% to 4.33April 10, 2026 | msn.comMaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 31, 2026 | globenewswire.comMaxCyte (MXCT) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | finance.yahoo.comMaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlookMarch 25, 2026 | seekingalpha.comMaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call TranscriptMarch 25, 2026 | insidermonkey.comMaxCyte, Inc. (MXCT) Q4 2025 Earnings Call TranscriptMarch 25, 2026 | seekingalpha.comMaxCyte Inc (MXCT) Q4 2025 Earnings Call Highlights: Navigating Revenue Declines Amid Strategic ...March 25, 2026 | uk.finance.yahoo.comMaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue EstimatesMarch 24, 2026 | zacks.comMaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 GuidanceMarch 24, 2026 | globenewswire.comMaxCyte Appoints Parmeet Ahuja as Chief Financial OfficerMarch 23, 2026 | globenewswire.comMaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discoveryFebruary 24, 2026 | globenewswire.comMaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026February 23, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBefore the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000By Jeffrey Neal Johnson | May 12, 2026NVIDIA’s China Connection: Investor Risks With Earnings AheadBy Thomas Hughes | May 5, 2026Years in the Making, AMD’s Upside Movement Has Just BegunBy Thomas Hughes | May 6, 2026Insiders Are Selling Big Tech, But Here Are 3 Reasons You May Not Want ToBy Thomas Hughes | April 28, 2026MXCT, ADV, MAST, and ABM Company DescriptionsABM Industries NYSE:ABM$40.20 +0.08 (+0.19%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$40.18 -0.02 (-0.04%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally. It operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments. The company offers janitorial, facilities engineering, and parking services for commercial real estate properties, including corporate offices for high tech clients, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities; provides vehicle maintenance and other services to rental car providers. It also offers integrated facility services, engineering, and other specialized services in various types of manufacturing, distribution, and data center facilities. In addition, the company delivers custodial and landscaping and grounds for public school districts, private schools, colleges, and universities. Further, it supports airlines and airports with services comprising passenger assistance, catering logistics, air cabin maintenance, and transportation services. Additionally, the company provides electric vehicle power design, installation, and maintenance, as well as microgrid systems installations. ABM Industries Incorporated was founded in 1909 and is headquartered in New York, New York.Advantage Solutions NASDAQ:ADV$42.31 +1.48 (+3.62%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$42.21 -0.10 (-0.24%) As of 05/22/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Advantage Solutions Inc. provides business solutions to consumer goods manufacturers and retailers in North America and internationally. It operates in two segments, Sales and Marketing. The Sales segment offers brand-centric services, such as headquarter relationship management; analytics, insights, and intelligence; and brand-centric merchandising services. This segment also provides retailer-centric services comprising retailer-centric merchandising and in-store media services. The Marketing segment offers brand-centric services, including shopper and consumer marketing, and brand experiential services; retailer-centric services, such as retail experiential and private label services; and digital marketing, and digital media and advertising services. The company was formerly known as Karman Holding Corp. and changed its name to Advantage Solutions Inc. in March 2016. The company was founded in 1987 and is headquartered in Irvine, California.MaxCyte NASDAQ:MXCT$1.04 -0.02 (-1.89%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.08 +0.04 (+3.85%) As of 05/22/2026 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
